These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32344856)

  • 1. Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias.
    De Bartolo MI; Manzo N; Ferrazzano G; Baione V; Belvisi D; Fabbrini G; Berardelli A; Conte A
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal sensory gating in patients with different types of focal dystonias.
    Conte A; Belvisi D; De Bartolo MI; Manzo N; Cortese FN; Tartaglia M; Ferrazzano G; Fabbrini G; Berardelli A
    Mov Disord; 2018 Dec; 33(12):1910-1917. PubMed ID: 30403835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatosensory temporal discrimination in patients with primary focal dystonia.
    Scontrini A; Conte A; Defazio G; Fiorio M; Fabbrini G; Suppa A; Tinazzi M; Berardelli A
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1315-9. PubMed ID: 19541688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 7. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported benefit and weakness after botulinum toxin in dystonia.
    Kassavetis P; Lungu C; Ehrlich D; Alter K; Karp BI
    Parkinsonism Relat Disord; 2020 Nov; 80():10-11. PubMed ID: 32927341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric changes of sensorimotor structures in focal dystonia.
    Obermann M; Yaldizli O; De Greiff A; Lachenmayer ML; Buhl AR; Tumczak F; Gizewski ER; Diener HC; Maschke M
    Mov Disord; 2007 Jun; 22(8):1117-23. PubMed ID: 17443700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department.
    Tomić A; Vujović B; Svetel M; Misković ND; Petrović I; Pekmezović T; Kostić VS
    Vojnosanit Pregl; 2015 Dec; 72(12):1069-73. PubMed ID: 26898029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Somatosensory Temporal Discrimination Threshold Change over Time in Focal Dystonia?
    Conte A; Ferrazzano G; Belvisi D; Manzo N; Suppa A; Fabbrini G; Berardelli A
    Neural Plast; 2017; 2017():9848070. PubMed ID: 29062576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.
    Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ
    Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: How Do You Treat Patients in Whom Botulinum Toxin Treatment Has No Effect?].
    Nomura T
    Brain Nerve; 2022 May; 74(5):581-587. PubMed ID: 35589651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of focal dystonia.
    Evinger C
    NeuroRx; 2005 Jul; 2(3):513-24. PubMed ID: 16389315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Neck Botulinum Neurotoxin Injection on Proprioception and Somatosensory-Motor Cortical Processing in Cervical Dystonia.
    Khosravani S; Buchanan J; Johnson MD; Konczak J
    Neurorehabil Neural Repair; 2020 Apr; 34(4):309-320. PubMed ID: 32102606
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term assessment of the risk of spread in primary late-onset focal dystonia.
    Abbruzzese G; Berardelli A; Girlanda P; Marchese R; Martino D; Morgante F; Avanzino L; Colosimo C; Defazio G
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):392-6. PubMed ID: 17635969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.